Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer.

Sci Rep · 2020 · PMC7713301 · PMID 33273652

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When we treated PKF mice with gemcitabine for 3 weeks starting from 4 weeks of age, VCAM-1 expression in PDAC tended to increase but did not reach statistical significance (Supplementary Fig. 1 H).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.